Positive therapeutic response to BCG or to its soluble fraction F70 in some patients with carcinoma of the skin, of the breast or of the larynx.
D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy*; D002280:Basal Cell Carcinoma / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000628:therapy*; D008175:Lung Neoplasms / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000628:therapy*
D001500:BCG Vaccine